ArticleFrontiers in genetics2026
Considering microRNAs as measures of extrinsic domains of risk in the context of underlying genetic characteristics: type 2 diabetes as an exemplar.
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The etiology of most health conditions is complex, arising from a combination of risk factors that include both intrinsic (i.e., genetic characteristics) and extrinsic (e.g., behaviors, the environment, social factors) domains. Until relatively recently, health science research typically conflated the biological construct of genetic ancestry with the social constructs of race and ethnicity. The advent of ancestry informative markers (AIMs) and related statistical methods marked an important advance, enabling the quantification of genetic ancestry independent of the constructs of race and ethnicity. Another type of molecular marker (microRNAs) has shown potential utility for quantifying extrinsic domains of risk, including behavioral, environmental, and social factors, within the context of underlying genetic characteristics. Given these markers offer distinct yet complementary information, combining them may provide a more rigorous and comprehensive approach to evaluating the combined domains of intrinsic genetic risk with extrinsic risk factors to improve accuracy in prediction of risk for complex diseases like type 2 diabetes (T2D).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.